Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Surinder Kaur

Showing results (91-100 of 151) with videos related to

Pageof 16
Sort By:
BMJ Open|October 5, 2013
A pragmatic randomised controlled trial of 'PhysioDirect' telephone assessment and advice services for patients with musculoskeletal problems: economic evaluationSandra Hollinghurst, Joanna Coast, John Busby, et al.
AIDS (London, England)|February 19, 2016
Differences in expression of gut-homing receptors on CD4+ T cells in black and white HIV-negative men who have sex with menColleen F Kelley, Lilin Lai, Chris Ibegbu, et al.
Frontiers in Cardiovascular Medicine|June 18, 2025
Real-world sex differences in healthcare utilization after cryoballoon ablation: 2-year outcomes from the Cryo Global RegistrySurinder Kaur Khelae, Kyoung Ryul Julian Chun, Christian Drephal, et al.
Journal of the American Heart Association|December 10, 2021
Cryoballoon Ablation for the Treatment of Atrial Fibrillation in Patients With Concomitant Heart Failure and Either Reduced or Preserved Left Ventricular Ejection Fraction: Results From the Cryo AF Global RegistryRoberto Rordorf, Fernando Scazzuso, Kyoung Ryul Julian Chun, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2009
Type I interferon (IFN)-dependent activation of Mnk1 and its role in the generation of growth inhibitory responsesSonali Joshi, Surinder Kaur, Amanda J Redig, et al.
Journal of Clinical Pharmacology|August 8, 2013
Population pharmacokinetic analysis from phase I and phase II studies of the humanized monovalent antibody, onartuzumab (MetMAb), in patients with advanced solid tumorsYan Xin, Denise Jin, Stephen Eppler, et al.
Molecular Cancer Therapeutics|November 22, 2013
Nonclinical evaluation of the serum pharmacodynamic biomarkers HGF and shed MET following dosing with the anti-MET monovalent monoclonal antibody onartuzumabElaine Mai, Zhong Zheng, Youjun Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Critical roles for mTORC2- and rapamycin-insensitive mTORC1-complexes in growth and survival of BCR-ABL-expressing leukemic cellsNathalie Carayol, Eliza Vakana, Antonella Sassano, et al.
Bioanalysis|November 9, 2019
Immunoaffinity LC-MS/MS to quantify a PEGylated anti-Factor D Fab biotherapeutic in cynomolgus monkey serumLuna Liu, Yanqiu Liu, Lu Dai, et al.
Oncotarget|October 17, 2015
The novel combination of dual mTOR inhibitor AZD2014 and pan-PIM inhibitor AZD1208 inhibits growth in acute myeloid leukemia via HSF pathway suppressionMasako Harada, Juliana Benito, Shinichi Yamamoto, et al.
Pageof 16

Showing results (91-100 of 151) with videos related to

Sort By:
Pageof 16
BMJ Open|October 5, 2013
A pragmatic randomised controlled trial of 'PhysioDirect' telephone assessment and advice services for patients with musculoskeletal problems: economic evaluationSandra Hollinghurst, Joanna Coast, John Busby, et al.
AIDS (London, England)|February 19, 2016
Differences in expression of gut-homing receptors on CD4+ T cells in black and white HIV-negative men who have sex with menColleen F Kelley, Lilin Lai, Chris Ibegbu, et al.
Frontiers in Cardiovascular Medicine|June 18, 2025
Real-world sex differences in healthcare utilization after cryoballoon ablation: 2-year outcomes from the Cryo Global RegistrySurinder Kaur Khelae, Kyoung Ryul Julian Chun, Christian Drephal, et al.
Journal of the American Heart Association|December 10, 2021
Cryoballoon Ablation for the Treatment of Atrial Fibrillation in Patients With Concomitant Heart Failure and Either Reduced or Preserved Left Ventricular Ejection Fraction: Results From the Cryo AF Global RegistryRoberto Rordorf, Fernando Scazzuso, Kyoung Ryul Julian Chun, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2009
Type I interferon (IFN)-dependent activation of Mnk1 and its role in the generation of growth inhibitory responsesSonali Joshi, Surinder Kaur, Amanda J Redig, et al.
Journal of Clinical Pharmacology|August 8, 2013
Population pharmacokinetic analysis from phase I and phase II studies of the humanized monovalent antibody, onartuzumab (MetMAb), in patients with advanced solid tumorsYan Xin, Denise Jin, Stephen Eppler, et al.
Molecular Cancer Therapeutics|November 22, 2013
Nonclinical evaluation of the serum pharmacodynamic biomarkers HGF and shed MET following dosing with the anti-MET monovalent monoclonal antibody onartuzumabElaine Mai, Zhong Zheng, Youjun Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Critical roles for mTORC2- and rapamycin-insensitive mTORC1-complexes in growth and survival of BCR-ABL-expressing leukemic cellsNathalie Carayol, Eliza Vakana, Antonella Sassano, et al.
Bioanalysis|November 9, 2019
Immunoaffinity LC-MS/MS to quantify a PEGylated anti-Factor D Fab biotherapeutic in cynomolgus monkey serumLuna Liu, Yanqiu Liu, Lu Dai, et al.
Oncotarget|October 17, 2015
The novel combination of dual mTOR inhibitor AZD2014 and pan-PIM inhibitor AZD1208 inhibits growth in acute myeloid leukemia via HSF pathway suppressionMasako Harada, Juliana Benito, Shinichi Yamamoto, et al.
Pageof 16